Hims & Hers Health, Inc. last reported quarterly results on Aug 10, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $753.2 million (+38.2% year over year) and diluted EPS of -$0.37. It usually reports 34–54 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 2, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Monday. Based on last year's release for the same quarter on Nov 3, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 34–54 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 10, 2026
41 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
753
+38.2%
|
-86
-303.0%
|
-0.37
-317.6%
|
|
May 11, 2026
41 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
608
+3.8%
|
-92
-286.1%
|
-0.40
-300.0%
|
|
Feb 23, 2026
54 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
618
+28.4%
|
21
-20.8%
|
0.08
-26.3%
|
|
Nov 3, 2025
34 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
599
+49.2%
|
16
-79.1%
|
0.06
-81.2%
|
|
Aug 4, 2025
35 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
545
+72.6%
|
43
+219.7%
|
0.17
+183.3%
|
|
May 5, 2025
35 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
586
+110.7%
|
49
+344.7%
|
0.20
+300.0%
|
|
Feb 24, 2025
55 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
481
+95.1%
|
26
+1990.4%
|
0.11
+1686.1%
|
|
Nov 4, 2024
35 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
402
+77.1%
|
76
+1098.9%
|
0.32
+900.0%
|
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- HIMS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1773751
- Former names
- Oaktree Acquisition Corp. (until Jan 19, 2021)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.